To Any/All who feel like answering:
Let's move to the
To Any/All who feel like answering:
Let's move to the point when the patient has been treated for a few months and his tumor burden has fallen substantially. It is about that time when PD-L1 has increased on the surfaces of CTCs and CTC quantity also has increased.
At this point, we can understand, that the Tumor has converted from being Cold to Being Hot.
First question is, when the tumor converts, is it still putting out RANTES? since it no longer depends on RANTES suppressive effects since the PD-1 pathway is keeping it alive?
If it is still emitting RANTES, and LL is on board still, I don't see the point of why the tumor would be doing that since there are no CCR5 receptors to bind to if LL is on board.
If it is not emitting RANTES, then there would be no problem in stopping LL administration once tumor goes Hot.
Question is, if LL is stopped, does the Tumor recognize the absence of LL and again resume to emitting RANTES in order to suppress the T Cells and also protect itself via PD-1?
Or once the tumor goes Hot, does it forsake RANTES communication entirely?
Last question, does it make most sense to maintain LL administration even while the Tumor has become Hot in order to protect against any RANTES resurgence?
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Rolling Through Winter: Lassa's Next Step Ever felt like you were skating on thin ice with your vehicle in winter? That's why Lassa has cranked out the Wintus 3—a tyre making waves in the chilly game. Now, we're not talking about your run-of-the-mill rubber. This is a strategic play by a Turkish powerhouse, Brisa, aimed squarely at those who rely on light commercial...
Continue Reading
Empowering the HS Community with Innovations Look, if you’ve walked a mile in someone else's shoes—particularly ones dealing with hidradenitis suppurativa (HS)—you’d know what a relentless grind managing those exuding wounds can be. Dimora Medical, known for navigating the tricky territory of wound care, threw its hat into the ring at the HS Connect Empower...
Continue Reading
New Leadership at Solenis Change is brewing at Solenis, and it's set to ripple across the water treatment industry like a stone in a pond. Brendy Lange's appointment as Chief Business Officer, Americas, promises to shake things up in a firm as committed to innovation as Solenis. This seasoned executive, scooped from the ranks of Dow Chemical, steps in with a mandate to...
Continue Reading
Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...
Continue Reading
Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...
Continue Reading
Clearing the Path for New Beginnings The ink's barely dry on Cboe Clear U.S.'s recent SEC registration, and it's already setting tongues wagging among market old-timers. This move to clear binary securities options alongside futures isn't just a step up; it's a signal flare for ambitious innovation. The Nuts and Bolts: SEC Registration So, what's the big to-do? Cboe Clear...
Continue Reading
This Isn't Just Another Cancer Update Alright, folks, let's unwrap what's happening today with Rakuten Medical. They've thrown some serious numbers into the ring at the ESMO Congress 2026 in Madrid. We're talking long-term follow-up results of their ASP-1929 photoimmunotherapy combined with pembrolizumab in tackling recurrent and metastatic head and neck squamous cell...
Continue Reading
A Partnership Rooted in Service and Faith Let's face it, support from major companies for nonprofits isn't exactly commonplace. But every so often, you run into a partnership that catches your eye, and this one's got a little extra heart. SAFE Structure Designs, known for its defense engineering prowess in Las Vegas, is throwing its weight behind Clearwater's 50 Legs....
Continue Reading
An Interactive Take on Digital Infrastructure The geniuses over at S&P Global Ratings have just unleashed a shiny new tool for number crunchers and market hawks who can't get enough data center action—an interactive dashboard. Maybe not everyone’s cup of tea, but hey, in the dog-eat-dog world of digital infrastructure, any edge counts. What's in the Data Center Soup?...
Continue Reading
A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...
Continue Reading
Top 5 Most Recently Viewed Articles
Global Market Movements Overview As global markets fluctuate, the recent movements indicate a dynamic investment landscape. On a notable trading day, U.S. markets concluded positively with the Dow Jones Industrial Average reaching an impressive record high, closing at 42,352.75. This uplift comes in the wake of a stronger-than-anticipated jobs report, easing any lingering...
Continue Reading
Stanley Black & Decker's Strategic Move Stanley Black & Decker, Inc. (NYSE: SWK) shares are seeing a positive uptick in the market as the company makes headlines with its significant announcement. The firm revealed its decision to divest its Consolidated Aerospace Manufacturing business, selling it to Howmet Aerospace for an impressive $1.8 billion in cash. Details Behind...
Continue Reading
Rosen Law Firm Investigates Securities Claims for Investors Rosen Law Firm, a leading advocate for investor rights, is actively looking into potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP). This initiative stems from serious allegations that the company may have disseminated misleading business information to its investors,...
Continue Reading
IMAGE Studios Introduces IMAGE Pro Academy IMAGE Studios is taking a significant step in empowering independent beauty and wellness entrepreneurs with the exciting launch of IMAGE Pro Academy. This new platform promises to be a comprehensive education hub, specially designed for professionals who seek to enhance their knowledge and skills in the competitive beauty...
Continue Reading
Badge Inc Achieves Recognition in Cybersecurity Sphere Badge Inc, a leader in privacy-enhancing identity solutions, has recently earned accolades for its innovations in cybersecurity. The company has been acknowledged as a recipient of the prestigious Fortress Cybersecurity Awards, marking a significant achievement in the realm of privacy technologies. This honor reflects...
Continue Reading